Asterivir ^None

Asterivir is a startup biotech/pharmaceutical company that has been working on developing broad-spectrum antiviral drugs for ten years at EPFL. Their technology has been proven effective in vitro and in vivo against various viruses, including Influenza, RSV, HSV2, and SARS-CoV-2. Their virucidal molecules attack virions in the body, destroying the virus before it can bind to healthy cells.